ELISA Kit for Lecithin Cholesterol Acyltransferase (LCAT)

phosphatidylcholine-sterol O-acyltransferase; Phospholipid-cholesterol acyltransferase

Specificity

This assay has high sensitivity and excellent specificity for detection of Lecithin Cholesterol Acyltransferase (LCAT).
No significant cross-reactivity or interference between Lecithin Cholesterol Acyltransferase (LCAT) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Lecithin Cholesterol Acyltransferase (LCAT) and the recovery rates were calculated by comparing the measured value to the expected amount of Lecithin Cholesterol Acyltransferase (LCAT) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-102 97
EDTA plasma(n=5) 78-96 90
heparin plasma(n=5) 94-102 99

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lecithin Cholesterol Acyltransferase (LCAT) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Lecithin Cholesterol Acyltransferase (LCAT) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Lecithin Cholesterol Acyltransferase (LCAT) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 89-99% 83-98% 96-103% 92-101%
EDTA plasma(n=5) 78-103% 86-94% 79-102% 89-98%
heparin plasma(n=5) 81-102% 96-105% 95-105% 91-98%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Int J Rheum Dis Plasma phospholipase, γ‐CEHC and antioxidant capacity in fibromyalgia PubMed: 26585319
Inflammation. Alteration of Lysophosphatidylcholine-Related Metabolic Parameters in the Plasma of Mice withExperimental Sepsis. pubmed:28028754
British journal of cancer A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. pubmed:28664912
Journal of Agricultural and Food Chemistry Lipid-lowering effects of medium-chain triglyceride-enriched coconut oil in combination with licorice extracts in experimental hyperlipidemic mice Pubmed: 30244576
Experimental and Therapeutic Medicine Identification and validation of differentially expressed proteins in serum of CSU patients with different duration of wheals using an iTRAQ labeling, 2D‑LC‑MS/MS Doi: 10.3892/etm.2018.6818
British Journal of Cancer Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel. Pubmed: 31388184
BIOMEDICINE & PHARMACOTHERAPY The synergistic mechanism of total saponins and flavonoids in Notoginseng− Safflower pair against myocardial ischemia uncovered by an integrated … Pubmed: 32739736
Biomedicine & Pharmacotherapy Pharmacokinetics/pharmacometabolomics-pharmacodynamics reveals the synergistic mechanism of a multicomponent herbal formula, Baoyuan decoction?¡­
Cell Metab Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression Pubmed:35235775
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPJ516Ra02 Recombinant Lecithin Cholesterol Acyltransferase (LCAT) Positive Control; Immunogen; SDS-PAGE; WB.
RPJ516Ra01 Recombinant Lecithin Cholesterol Acyltransferase (LCAT) Positive Control; Immunogen; SDS-PAGE; WB.
PAJ516Ra01 Polyclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) WB; IHC; ICC; IP.
PAJ516Ra02 Polyclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) WB; IHC; ICC; IP.
LAJ516Ra71 Biotin-Linked Polyclonal Antibody to Lecithin Cholesterol Acyltransferase (LCAT) WB; IHC; ICC.
SEJ516Ra ELISA Kit for Lecithin Cholesterol Acyltransferase (LCAT) Enzyme-linked immunosorbent assay for Antigen Detection.
LMJ516Ra Multiplex Assay Kit for Lecithin Cholesterol Acyltransferase (LCAT) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.